Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 January, 2019 00:34 IST
Alembic Pharma receives USFDA tentative approval for lloperidone Tablets
Source: IRIS | 12 Jul, 2018, 10.46AM
Comments  |  Post Comment

Alembic Pharmaceuticals Wednesday announced that the company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for lloperidone tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg.

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Fanapt Tablets, 1 mg, 2 mg, 4 mg, 6 mg, 8 mg, 10 mg and 12 mg, of Vanda Pharmaceuticals, Inc. lloperidone tablets are indicated for the treatment of schizophrenia inadults.

lloperidone Tablets have an estimated market size of US$ 128 million for twelve months ending December 2017 according to IQVIA.

Alembic now has a total of 74 ANDA approvals (65 final approvals and 9 tentative approvals) from USFDA.

Shares of the company gained Rs 7.1, or 1.34%, to trade at Rs 538.00. The total volume of shares traded was 708 at the BSE (10.33 a.m., Thursday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
LIC completes 51% controlling acquisition in IDBI Bank - 22-Jan-2019 10:25
Lupin receives FDA approval for Levothyroxine Sodium Tablets USP - 21-Jan-2019 17:08
Zydus gets tentative approval from USFDA for Esomeprazole Magnesium Delayed-Release - 21-Jan-2019 16:10
SBI witnessed overwhelming response for its USD 1.25 mn bonds issue - 21-Jan-2019 10:57
HDFC Bank Q3 earnings grow 20% to Rs 55.85 bn - 21-Jan-2019 10:54
BHEL and Libcoin in dialogue to build India's first lithium ion factory - 21-Jan-2019 10:32
BHEL to set up solar electric vehicle chargers along Delhi-Chandigarh highway - 21-Jan-2019 10:28
Wockhardt receives USFDA approval for Leukemia drug - 21-Jan-2019 10:20
Ratnamani Metals & Tubes receives order worth Rs 2 bn - 18-Jan-2019 15:59
Aurobindo Pharma to acquire portfolio of oncology injectables products - 18-Jan-2019 13:47
Reliance Ind Q3 earnings up 8.8%; GRM's at USD 8.8/bbl - 18-Jan-2019 13:08
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer